Skip to content

Medical emergency? What to do

Obesity predicts prostate cancer recurrence

3-RXPublished August 21, 20072 min read

Key points

  • Obese men have an increased risk of prostate cancer recurrence and death after they have completed radiation therapy, according to results of a study published in the medical journal BJU International.
  • The researchers therefore examined whether obesity is associated with outcome for patients who undergo external beam radiation therapy for prostate cancer.
  • Blood levels of the male hormone testosterone were lower in obese men than in overweight and normal-weight men.
  • The average times to prostate cancer death were 11.1 years for normal and overweight men, and 10.6 years for obese men, a statistically significant difference.

Obese men have an increased risk of prostate cancer recurrence and death after they have completed radiation therapy, according to results of a study published in the medical journal BJU International.

Obesity is known to predict prostate cancer progression in men who undergo radical prostatectomy, or complete surgical removal of the prostate gland, Dr. David Palma and colleagues from the British Columbia Cancer Agency, Vancouver, Canada, pointed out.

The researchers therefore examined whether obesity is associated with outcome for patients who undergo external beam radiation therapy for prostate cancer. Of 706 patients treated with radiation from 1994 through 2000, 195 were normal weight, 358 were overweight, and 153 were obese.

There were no significant differences among the three groups in Gleason score (aggressiveness of the tumor); prostate-specific antigen (PSA) score (a prostate tumor marker) before treatment began; or cancer stage (how far the cancer has spread).

Blood levels of the male hormone testosterone were lower in obese men than in overweight and normal-weight men.

There were a total of 292 treatment failures detected by laboratory tests. The average times to relapse for normal-weight, overweight, and obese men were 93 months, 88 months, and 84 months, respectively.

The average times to prostate cancer death were 11.1 years for normal and overweight men, and 10.6 years for obese men, a statistically significant difference. The results of further analysis revealed a trend toward decreased overall survival by weight group.

"A number of explanations have been postulated to account for more aggressive prostate cancer in obese men," Palma and colleagues note. "Possible mechanisms include dietary factors, and alterations in hormonal levels, such as estrogens, androgens, leptin, and IGF-1, although definitive mechanisms have not been elucidated."

SOURCE: BJU International, August 2007.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Keep reading

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.